Skip to main content
. 2018 Feb 5;2018:5604702. doi: 10.1155/2018/5604702

Table 1.

Patient characteristics.

Age, ave. ± SD (min-max) 64.0 ± 12.2 (42–88)

Age, n (%) <50-year-old 7 (14.0)
50-70-year-old 26 (52.0)
>70-year-old 17 (34.0)

Gender, n (%) Male 34 (68.0)
Female 16 (32.0)

Operation, n (%) R0 resection 44 (88.0)
Subtotal gastrectomy 24 (48.0)
Total gastrectomy 20 (40.0)
Palliative 6 (12.0)

Pathology, n (%) Adenocancer 50 (100)

Tumor A, ave. ± SD (min-max) 34.1 ± 6.7 (21–47)

Clinical T, n (%) 3 40 (80.0)
4 10 (20.0)

Clinical N, n (%) Positive 19 (38.0)

Clinical stage, n (%) 2 30 (60.0)
3 20 (40.0)

Pathological N, ave. ± SD (min-max) 7.5 ± 5.4 (1–18)

Total lymph node, ave. ± SD (min-max) 15.4 ± 6.2 (0–24)

Pathological stage, n (%) 2B 7 (14.0)
3A 12 (24.0)
3B 14 (28.0)
3C 11 (22.0)
4 6 (12.0)

Wound infection, n (%) 9 (18.0)
Anastomose leak, n (%) 9 (18.0)
Ileus, n (%) 4 (8.0)
Atelectasis, n (%) 4 (8.0)
Mortality, n (%) 14 (28.0)